South African children will have to wait until next year for the rollout of the child friendly, ‘sweet-tasting’ antiretroviral (ARV) treatment, despite this new 4-in-1 combination receiving the green light. The South African Health Products Regulatory Authority (SAHPRA) approved the combo, which includes abacavir, lamivudine, lopinavir, and ritonavir in June. But the National Department of … Continue reading Slow rollout for child-friendly ARV treatment